PharMerica CORP Deferred Tax Assets, Valuation Allowance
PharMerica CORP had Deferred Tax Assets, Valuation Allowance of $2.60 million as of 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2017-02-24
- 2016-12-31: Deferred Tax Assets, Valuation Allowance $2.60M.
- 2015-12-31: Deferred Tax Assets, Valuation Allowance $3.80M.
- 2014-12-31: Deferred Tax Assets, Valuation Allowance $4.10M.
- 2014-09-30: Deferred Tax Assets, Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2016-12-31 | $2.60M 10-K · filed 2017-02-24 |
| 2015-12-31 | $3.80M 10-K · filed 2017-02-24 |
| 2014-12-31 | $4.10M 10-K · filed 2016-02-26 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 |
| 2014-06-30 | $4.10M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $4.10M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $4.10M 10-K · filed 2015-03-02 |
| 2013-09-30 | $1.00M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $1.00M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $1.00M 10-Q · filed 2013-05-01 |
| 2012-12-31 | $1.00M 10-K · filed 2014-02-28 |
| 2012-09-30 | $1.00M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $1.00M 10-Q · filed 2012-08-02 |
| 2011-12-31 | $1.00M 10-K · filed 2013-02-07 |